J. Francis

CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells.

Claude Chelala, Ming Yuan, Kangdong Liu, 2009, The Journal of clinical investigation.

Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer

N. Lemoine, Z. Dong, T. Timiryasova, 2009, Gene Therapy.

Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus

Yufei Wang, D. Kirn, N. Lemoine, 2005, Gene Therapy.

Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus.

P. Roberts, S. Agrawal, D. Szymkowski, 2000, Antiviral research.

An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potency.

D. Kirn, N. Lemoine, Yaohe Wang, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models

R. Hill, D. Kirn, N. Lemoine, 2003, Nature Biotechnology.

A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses.

D. Kirn, N. Lemoine, S. Thorne, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.

N. Lemoine, B. Griffin, Yaohe Wang, 2005, Cancer research.

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.

R. Hill, D. Kirn, N. Lemoine, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine

N. Lemoine, N. Lemoine, J. Francis, 2011, Cancer Gene Therapy.